Quest to use Matrix-Bio-developed biomarkers for breast cancer test

04/12/2013 | GenomeWeb Daily News (free registration)

Quest Diagnostics has licensed the rights to biomarkers developed by Matrix-Bio in an effort to create a clinical test for recurrent breast cancer. Matrix-Bio Founder and CSO Dan Raftery called the move "a big step toward our goal to make improved and more efficient testing methods for diagnosing many forms of cancer available to physicians and patients."

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA